Pyxis Oncology, Inc.
NASDAQ:PYXSBiotechnology
Healthcare
$1.44 +5.53%
+$0.11 today
- Market cap
- $172.24M
- Beta
- 1.43
- P/E (TTM)
- -1.6
- EPS (TTM)
- -$1.29
52W Low $0.97High $5.55
Volume 1.44M
Average 0.50M
Price history
Pyxis Oncology, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-69.49%
Period high
$5.34
Period low
$1.06
Latest
$1.44
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 13, 2026 | Nov 13, 2026 | |
| 4 | Nov 6, 2026 | Nov 6, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G/A | Nov 3, 2026 | Nov 3, 2026 | |
| DEF 14A | Oct 21, 2026 | Oct 21, 2026 | |
| SC 13G/A | Oct 9, 2026 | Oct 9, 2026 | |
| 4/A | Oct 9, 2026 | Oct 9, 2026 | |
| PRE 14A | Oct 9, 2026 | Oct 9, 2026 | |
| SC 13G | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| SC 13G/A | Oct 2, 2026 | Oct 2, 2026 | |
| 424B5 | Oct 1, 2026 | Oct 1, 2026 | |
| 8-K | Oct 1, 2026 | Oct 1, 2026 | |
| 424B5 | Sep 29, 2026 | Sep 29, 2026 |
Competitors
Who does Pyxis Oncology, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about PYXS's filings, answered from its disclosures.
What is the latest PYXS filing?
The latest filing shown is 8-K dated Nov 13, 2026.
How many recent filings does PYXS have?
Intrinsic Alpha currently shows 20 recent filings for PYXS.
Continue the stock analysis
Jump to another research area for this company.